Minaris Advanced Therapies
Global Cell Gene Therapy
- B2B
About Minaris Advanced Therapies
Global cell and gene therapy CDMO and biosafety testing provider with deep experience supporting therapeutic programs from IND through commercial supply.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- Philadelphia, Pennsylvania, United States
- Founded
- 2025
- Revenue
- $107M – $847MTamtam estimate
- Website
- minaris.com
Jobs at Minaris Advanced Therapies
Minaris Advanced Therapies in the news
- Bionova Scientific and Minaris Announce Partnership to Accelerate Plasmid DNA Supply for Cell and Gene Therapy Manufacturing | Newswise
Bionova Scientific and Minaris announced a strategic partnership to expand access to high-quality plasmid DNA for advanced therapy development and manufacturing.
- Building Commercial Readiness in Advanced Therapies
Eytan Abraham discusses the critical manufacturing decisions and challenges in scaling advanced therapies from development to commercialization for broader patient access.
- Minaris Expands Its Apprentice.io Partnership, Bringing Digital Manufacturing to Its Philadelphia Headquarters
Minaris Advanced Therapies is expanding its digital manufacturing platform partnership with Apprentice.io to its global sites, including its Philadelphia headquarters, to enhance efficiency and collaboration in cell and gene therapy production.
- Minaris Enhances GMP Cell Banking Suites at Philadelphia Facility
Minaris upgraded its Philadelphia facility's GMP cell banking suites to provide integrated cell banking and biosafety testing services for cell and gene therapy programs.
- Minaris Enhances GMP Cell Banking Capabilities at Philadelphia Facility
Upgraded GMP cell banking suites at the Philadelphia facility now offer integrated biosafety testing and expanded manufacturing capacity for cell and gene therapy developers.
Minaris Advanced Therapies at a glance
Minaris Advanced Therapies is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Philadelphia, Pennsylvania, United States.
Minaris Advanced Therapies was founded in 2025.
Minaris Advanced Therapies has 251–1,000 employees.
Minaris Advanced Therapies's revenue is $107M – $847M (Tamtam estimate).
Minaris Advanced Therapies is hiring: 1 recent open role, including Production Support Associate I.
Selling to companies like Minaris Advanced Therapies?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies